Literature DB >> 11947967

Diabetes in Ghana: a community based prevalence study in Greater Accra.

Albert G B Amoah1, Samuel K Owusu, Samuel Adjei.   

Abstract

Data on the prevalence of diabetes in Ghana is scanty and unreliable. In the present study we have ascertained the prevalence of diabetes, impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT) in a random cluster sample of Ghanaians aged 25 years and above from the Greater Accra area of Ghana. Diabetes, IFG and IGT were defined by criteria of the American Diabetes Association and World Health Organization. The mean age of the 4733 subjects involved in the study was 44.3+/-14.7 years, and participation rate was 75%. The crude prevalence of diabetes was 6.3%. Out of 300 subjects with diabetes, 209 (69.7%) had no prior history of the disease. Diabetes, IGT and combined IFG and IGT increased with age. The oldest age group (64+ years) had the highest diabetes prevalence (13.6%). The age-adjusted prevalence of diabetes, IFG and IGT, were 6.4, 6.0 and 10.7%, respectively. Diabetes was more common in males than females (7.7 vs. 5.5%) [P<0.05]. Worsening glycaemic status tended to be associated with increase in age, body mass index, systolic and diastolic blood pressures. Ascertainment of predictors for diabetes in Ghanaians and the significance of the relatively high rates of and IFG and IGT however, remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11947967     DOI: 10.1016/s0168-8227(01)00374-6

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  75 in total

1.  The answer to diabetes prevention: science, surgery, service delivery, or social policy?

Authors:  Ruth Colagiuri; Stephen Colagiuri; Derek Yach; Stig Pramming
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

2.  Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry.

Authors:  Iva Miljkovic; Jane A Cauley; Moira A Petit; Kristine E Ensrud; Elsa Strotmeyer; Yahtyng Sheu; Christopher L Gordon; Bret H Goodpaster; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Lewis H Kuller; Kimberly A Faulkner; Joseph M Zmuda
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

Review 3.  Irrational use of antibiotics and the risk of diabetes in Ghana.

Authors:  Kwesi B Mensah; Charles Ansah
Journal:  Ghana Med J       Date:  2016-06

4.  Preventing Diabetes and Atherosclerosis in Sub-Saharan Africa: Should the Metabolic Syndrome Have a Role?

Authors:  Omoye E Imoisili; Anne E Sumner
Journal:  Curr Cardiovasc Risk Rep       Date:  2009-01-01

Review 5.  A comprehensive review of the policy and programmatic response to chronic non-communicable disease in Ghana.

Authors:  W K Bosu
Journal:  Ghana Med J       Date:  2012-06

6.  Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Authors:  N A A Amartey; K Nsiah; F O Mensah
Journal:  J Clin Diagn Res       Date:  2015-02-01

7.  Haptoglobin polymorphism and association with complications in ghanaian type 2 diabetic patients.

Authors:  Michael B Adinortey; Ben A Gyan; Jonathan P Adjimani; Philomena E Nyarko; Charity Sarpong; Francis Y Tsikata; Alexander K Nyarko
Journal:  Indian J Clin Biochem       Date:  2011-05-13

8.  Prevalence of glaucoma in an urban West African population: the Tema Eye Survey.

Authors:  Donald L Budenz; Keith Barton; Julia Whiteside-de Vos; Joyce Schiffman; Jagadeesh Bandi; Winifred Nolan; Leon Herndon; Hanna Kim; Graham Hay-Smith; James M Tielsch
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

9.  A study on the prevalence of type 2 diabetes in coastal Karnataka.

Authors:  Chythra R Rao; Veena G Kamath; Avinash Shetty; Asha Kamath
Journal:  Int J Diabetes Dev Ctries       Date:  2010-04

10.  Smoking uptake and prevalence in Ghana.

Authors:  E Owusu-Dabo; S Lewis; A McNeill; A Gilmore; J Britton
Journal:  Tob Control       Date:  2009-07-05       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.